Water-filtered infrared-A (wIRA) can act as a penetration enhancer for topically applied substances.
BACKGROUND
Water-filtered infrared-A (wIRA) irradiation has been shown to enhance penetration of clinically used topically applied substances in humans through investigation of functional effects of penetrated substances like vasoconstriction by cortisone.


OBJECTIVE
Investigation of the influence of wIRA irradiation on the dermatopharmacokinetics of topically applied substances by use of optical methods, especially to localize penetrating substances, in a prospective randomised controlled study in humans.


METHODS
The penetration profiles of the hydrophilic dye fluorescein and the lipophilic dye curcumin in separate standard water-in-oil emulsions were determined on the inner forearm of test persons by tape stripping in combination with spectroscopic measurements. Additionally, the penetration was investigated in vivo by laser scanning microscopy. Transepidermal water loss, hydration of the epidermis, and surface temperature were determined. Three different procedures (modes A, B, C) were used in a randomised order on three separate days of investigation in each of 12 test persons. In mode A, the two dyes were applied on different skin areas without water-filtered infrared-A (wIRA) irradiation. In mode B, the skin surface was irradiated with wIRA over 30 min before application of the two dyes (Hydrosun radiator type 501, 10 mm water cuvette, orange filter OG590, water-filtered spectrum: 590-1400 nm with dominant amount of wIRA). In mode C, the two dyes were applied and immediately afterwards the skin was irradiated with wIRA over 30 min. In all modes, tape stripping started 30 min after application of the formulations. Main variable of interest was the ratio of the amount of the dye in the deeper (second) 10% of the stratum corneum to the amount of the dye in the upper 10% of the stratum corneum.


RESULTS
The penetration profiles of the hydrophilic fluorescein showed in case of pretreatment or treatment with wIRA (modes B and C) an increased penetration depth compared to the non-irradiated skin (mode A): The ratio of the amount of the dye in the deeper (second) 10% of the stratum corneum to the amount of the dye in the upper 10% of the stratum corneum showed medians and interquartile ranges for mode A of 0.017 (0.007/0.050), for mode B of 0.084 (0.021/0.106), for mode C of 0.104 (0.069/0.192) (difference between modes: p=0.0112, significant; comparison mode A with mode C: p<0.01, significant). In contrast to fluorescein, the lipophilic curcumin showed no differences in the penetration kinetics, in reference to whether the skin was irradiated with wIRA or not. These effects were confirmed by laser scanning microscopy. Water-filtered infrared-A irradiation increased the hydration of the stratum corneum: transepidermal water loss rose from approximately 8.8 g m(-2) h(-1) before wIRA irradiation to 14.2 g m(-2) h(-1) after wIRA irradiation and skin hydration rose from 67 to 87 relative units. Skin surface temperature increased from 32.8 degrees C before wIRA to 36.4 degrees C after wIRA irradiation.


CONCLUSIONS
The better penetration of the hydrophilic dye fluorescein after or during skin irradiation (modes B and C) can be explained by increased hydration of the stratum corneum by irradiation with wIRA.


CONCLUSIONS
As most topically applied substances for the treatment of patients are mainly hydrophilic, wIRA can be used to improve the penetration of substances before or after application of substances - in the first case even of thermolabile substances - with a broad clinical relevance as a contact free alternative to an occlusive dressing.
Otberg
Nina
N
Department of Dermatology, Center of Experimental and Applied Cutaneous Physiology, University Medicine Charité, Berlin, Germany.
Grone
Diego
D
Meyer
Lars
L
Schanzer
Sabine
S
Hoffmann
Gerd
G
Ackermann
Hanns
H
Sterry
Wolfram
W
Lademann
Jürgen
J
J Invest Dermatol. 1998 Oct;111(4):629-33
9764844
Skin Pharmacol Appl Skin Physiol. 2001;14 Suppl 1:98-102
11509914
GMS Krankenhhyg Interdiszip. 2008 Mar 05;2(2):Doc52
20204086
Ger Med Sci. 2008 Oct 21;6:Doc11
19675738
Dermatol Monatsschr. 1990;176(11):683-6
2083608
Br J Surg. 2006 Aug;93(8):952-60
16845694
J Invest Dermatol. 2003 Oct;121(4):706-12
14632185
Skin Pharmacol Appl Skin Physiol. 1999 Jan-Apr;12(1-2):46-53
10325583
Skin Pharmacol Appl Skin Physiol. 1999 Sep-Oct;12(5):247-56
10461093
J Invest Dermatol. 1983 Sep;81(3):275-8
6886476
Skin Pharmacol Appl Skin Physiol. 2003 Jul-Aug;16(4):228-36
12784062
Ger Med Sci. 2007 Nov 14;5:Doc08
19675716
Z Geburtshilfe Neonatol. 2000 May-Jun;204(3):85-92
10909163
Ger Med Sci. 2004 Oct 29;2:Doc08
19675691
Adv Exp Med Biol. 1994;345:181-8
8079706
J Biomed Opt. 2003 Oct;8(4):601-7
14563197
Arch Dermatol Res. 1982;274(1-2):57-64
7165368
Ger Med Sci. 2006 Jul 11;4:Doc05
19675696
Skin Pharmacol. 1992;5(2):99-107
1637565
GMS Krankenhhyg Interdiszip. 2007 Dec 28;2(2):Doc54
20204085
Ger Med Sci. 2005 Mar 04;3:Doc01
19675718
Hautarzt. 2007 Nov;58(11):923-4
17955204
Arch Dermatol Res. 1987;279(5):351-6
3632037
Int J Mol Med. 2000 Mar;5(3):247-51
10677564
Skin Pharmacol Appl Skin Physiol. 2003 Jul-Aug;16(4):217-27
12784061
GMS Krankenhhyg Interdiszip. 2007 Dec 28;2(2):Doc53
20204084